A. Gutierrez

A. Gutierrez

Auto-generated profile, based on publicly available information

A. Gutierrez

Medical Oncology, 58 Regional Hospital IMSS, Leon, Mexico

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2019 in Acta Oncologica
Verified
Journal Article
Open access
AGA. Gutierrez
A. Gutierrez
VRV. Rompokos
V. Rompokos
KLK. Li
K. Li
CGC. Gillies
C. Gillies
DDD. D’souza
D. D’souza
TUT. Underwood
T. Underwood
Purpose: Pediatric craniopharyngioma, adult base-of-skull sarcoma and chordoma cases are all regarded as priority candidates for proton therapy. In this study, a dosimetric comparison between volumetric modulated arc therapy (VMAT) and intensity modulated proton therapy (IMPT) was first performed. We then investigated the impact of physical and biological uncertainties. We assessed whether IMPT plans remained dosimetrically superior when such uncertainty estimates were considered, especially with regards to sparing organs at risk (OARs). Methodology: We studied 10 cases: four chondrosarcoma, two chordoma and four pediatric craniopharyngioma. VMAT and IMPT plans were created according to modality-specific protocols. For IMPT, we considered (i) variable RBE modeling using the McNamara model for different values of (α/β)x, and (ii) robustness analysis with ±3 mm set-up and 3.5% range uncertainties. Results: When comparing the VMAT and IMPT plans, the dosimetric advantages of IMPT were clear: IMPT led to reduced integral dose and, typically, improved CTV coverage given our OAR constraints. When physical robustness analysis was performed for IMPT, some uncertainty scenarios worsened the CTV coverage but not usually beyond that achieved by VMAT. Certain scenarios caused OAR constraints to be exceeded, particularly for the brainstem and optical chiasm. However, variable RBE modeling predicted even more substantial hotspots, especially for low values of (α/β)x. Variable RBE modeling often prompted dose constraints to be exceeded for critical structures. Conclusion: For base-of-skull and pediatric craniopharyngioma cases, both physical and biological robustness analyses should be considered for IMPT: these analyses can substantially affect the sparing of OARs and comparisons against VMAT. All proton RBE modeling is subject to high levels of uncertainty, but the clinical community should remain cognizant possible RBE effects. Careful clinical and imaging follow-up, plus further research on end-of-range RBE mitigation strategies such as LET optimization, should be prioritized for these cohorts of proton patients.

1 May 2021 in Annals of Oncology
Verified
Journal Article
Closed access
GSG. Sanchez
G. Sanchez
AGA. Gutierrez
A. Gutierrez
JJJ.C. Jímenez
J.C. Jímenez
RCRicardo Correa
Ricardo Correa
Jorge Adan Alegría BañosJorge Adan Alegría Baños
Jorge Adan Alegría Baños
RAR.C. Grajales Alvarez
R.C. Grajales Alvarez